Ir para o conteúdo
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Palavra solta
Título
Autor
Assunto
Área/Cota
ISBN/ISSN
Tag
Pesquisar
Avançada
Biomarkers for Alzheimer's dis...
Citar
Enviar por SMS
Enviar por email
Imprimir
Exportar registo
Exportar para RefWorks
Exportar para EndNoteWeb
Exportar para EndNote
Permanent link
Biomarkers for Alzheimer's disease therapeutic trials
Show other versions (1)
Detalhes bibliográficos
Main Authors:
Hampel, H
,
Wilcock, G
,
Andrieu, S
,
Aisen, P
,
Blennow, K
,
Broich, K
,
Carrillo, M
,
Fox, N
,
Frisoni, G
,
Isaac, M
,
Lovestone, S
,
Nordberg, A
,
Prvulovic, D
,
Sampaio, C
,
Scheltens, P
,
Weiner, M
,
Winblad, B
,
Coley, N
,
Vellas, B
Formato:
Journal article
Publicado em:
2010
Exemplares
Descrição
Other Versions (1)
Registos relacionados
Registo fonte
A mostrar
1 - 1
resultados de
1
Show all versions (2)
Search Result 1
Biomarkers for Alzheimer's disease therapeutic trials.
Por
Hampel, H
,
Wilcock, G
,
Andrieu, S
,
Aisen, P
,
Blennow, K
,
Broich, K
,
Carrillo, M
,
Fox, N
,
Frisoni, G
,
Isaac, M
,
Lovestone, S
,
Nordberg, A
,
Prvulovic, D
,
Sampaio, C
,
Scheltens, P
,
Weiner, M
,
Winblad, B
,
Coley, N
,
Vellas, B
Publicado em 2011
Journal article
Show all versions (2)
Registos relacionados
Biomarkers for Alzheimer's disease therapeutic trials.
Por: Hampel, H, et al.
Publicado em: (2011)
Endpoints for trials in Alzheimer's disease: a European task force consensus.
Por: Vellas, B, et al.
Publicado em: (2008)
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force.
Por: Vellas, B, et al.
Publicado em: (2013)
Disease-modifying trials in Alzheimer's disease: a European task force consensus.
Por: Vellas, B, et al.
Publicado em: (2007)
Methodological issues in primary prevention trials for neurodegenerative dementia.
Por: Andrieu, S, et al.
Publicado em: (2009)